2011•Unpublished venueRequires access

Determination and Validation of Metformin, Glimepiride, Pioglitazone Using Atorvastatin as an Internal Standardin Bulk Drug and Pharmaceutical Dosage Form

Phani Raja, J C Thejaswini, Bannimath Gurupadayya, K Sowjanya

Open publisher page 2 citations

Abstract

A simple, fast, and precise reverse phase, High Performance Liquid Chromatography (HPLC) method was developed for the separation and quantio cation of Metformin HCl, Glimepiride and Pioglitazone in bulk drug and pharmaceutical dosage form using atorvastatin as internal standard. The quantio cation was carried out using C 18 (250 × 4.6mm, 5�� ) column and mobile phase comprising of methanol and phosphate buffer (pH 3) in proportion of 75:25 (v/v). Flow rate was maintained at the rate of 1.0 ml/ min and the ef?uent was monitored at 230 nm. Percentage recoveries of the drugs from the tablet formulation were found to be 98.6%, 104.6% and 99.42% for metformin, pioglitazone and glimepiride respectively. Hence, the proposed method was found to be suitable for simultaneous determination of metformin, pioglitazone and glimepiride in pharmaceutical dosage form and bulk drug.

About this research paper

What this paper is about

A simple, fast, and precise reverse phase, High Performance Liquid Chromatography (HPLC) method was developed for the separation and quantio cation of Metformin HCl, Glimepiride and Pioglitazone in bulk drug and pharmaceutical dosage form using atorvastatin as internal standard. The quantio cation was carried out using C 18 (250 × 4.6mm, 5�� ) column and mobile phase comprising of methanol and phosphate buffer (pH 3) in proportion of 75:25 (v/v). Flow rate was maintained at the rate of 1.0 ml/ min and the ef?uent was monitored at 230 nm. Percentage recoveries of the drugs from the tablet formulation were found to be 98.6%, 104.6% and 99.42% for metformin, pioglitazone and glimepiride respectively. Hence, the proposed method was found to be suitable for simultaneous determination of metformin, pioglitazone and glimepiride in pharmaceutical dosage form and bulk drug.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A simple, fast, and precise reverse phase, High Performance Liquid Chromatography (HPLC) method was developed for the separation and quantio cation of Metformin HCl, Glimepiride and Pioglitazone in bulk drug and pharmaceutical dosage form using atorvastatin as internal standard. The quantio cation was carried out using C 18 (250 × 4.6mm, 5�� ) column and mobile phase comprising of methanol and phosphate buffer (pH 3) in proportion of 75:25 (v/v). Flow rate was maintained at the rate of 1.0 ml/ min and the ef?uent was monitored at 230 nm. Percentage recoveries of the drugs from the tablet formulation were found to be 98.6%, 104.6% and 99.42% for metformin, pioglitazone and glimepiride respectively. Hence, the proposed method was found to be suitable for simultaneous determination of metformin, pioglitazone and glimepiride in pharmaceutical dosage form and bulk drug.

Key concepts: Glimepiride, Pioglitazone, Metformin, Dosage form, Chromatography, Chemistry, Atorvastatin, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Determination and Validation of Metformin, Glimepiride, Pioglitazone Using Atorvastatin as an Internal Standardin Bulk Drug and Pharmaceutical Dosage Form — Research Paper | ScholarLens